Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Clinical Dentistry

Journal Scan / Research · March 07, 2022

Effect of Botulinum Toxin Type A on Psychosocial Features of Patients With TMD and Myofascial Pain

Journal of Oral & Facial Pain and Headache

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Oral & Facial Pain and Headache
Effects of Botulinum Toxin Type A on the Psychosocial Features of Myofascial Pain TMD Subjects: A Randomized Controlled Trial
J Oral Facial Pain Headache 2022 Jan 06;35(4)288-296, G De la Torre Canales, RL Poluha, YN Alvarez Pinzón, PC Rodrigues Conti, D Manfredini, A Sánchez-Ayala, CM Rizzatti-Barbosa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading